55
52
Growth Score
-2 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
246782
European Independent Fully Owned Dedicated Site Network & DCT Service Provider | Clinical Trials & Patient Recruitment
Iwona Tongbhoyai: Chief Client Solutions OfficerPast Role: Synexus, Managing Director, Germany
Radoslaw Janiak: Chief Executive OfficerPast Role: Radwan Clinical Reserch Center, Clinical Trial Manager
About the Company
FutureMeds is an independent, fully-owned European Site Network and DCT service provider dedicated to running patient-centric clinical trials and delivering quality data for the world’s leading Sponsors & CROs.
With 28+ strategically located sites across 7 European countries, over 220 experienced investigators, and more than 1400 homecare
providers, FutureMeds offers site and DCT solutions across most therapeutic areas and provides reliability, efficiency and accuracy to help clients accelerate patient access to new treatments.
To learn more about how FutureMeds can support your trial, reach out to our team or visit futuremeds.com
